13 research outputs found
Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume
Background: We evaluated whether pre- and mid-treatment metabolic tumor volume (MTV) predicts per lesion local recurrence (LR) in patients treated with definitive radiation therapy (RT, dose≥60 Gy) for locally advanced non-small cell lung cancer (NSCLC).
Methods: We retrospectively reviewed records of patients with stage III NSCLC treated from 2006 to 2018 with pre- and mid-RT PET-CT. We measured the MTV of treated lesions on the pre-RT (MTVpre) and mid-RT (MTVmid) PET-CT. LR was defined per lesion as recurrence within the planning target volume. Receiver operating characteristic (ROC) curves, cumulative incidence rates, and uni- and multivariable (MVA) competing risk regressions were used to evaluate the association between MTV and LR.
Results: We identified 111 patients with 387 lesions (112 lung tumors and 275 lymph nodes). Median age was 68 years, 69.4% were male, 46.8% had adenocarcinoma, 39.6% had squamous cell carcinoma, and 95.5% received concurrent chemotherapy. Median follow-up was 38.7 months. 3-year overall survival was 42.3%. 3-year cumulative incidence of LR was 26.8% per patient and 11.9% per lesion. Both MTVpre and MTVmid were predictive of LR by ROC (AUC = 0.71 and 0.76, respectively) and were significantly associated with LR on MVA (P = 0.004 and P = 7.1e-5, respectively). Among lesions at lower risk of LR based on MTVpre, higher MTVmid was associated with LR (P = 0.001).
Conclusion: Per-lesion, larger MTVpre and MTVmid predicted for increased risk of LR. MTVmid was more highly predictive of LR than MTVpre and if validated may allow for further discrimination of high-risk lesions at mid-RT informing dose painting strategies
Evaluation of GPT-3.5 and GPT-4 for supporting real-world information needs in healthcare delivery
Despite growing interest in using large language models (LLMs) in healthcare,
current explorations do not assess the real-world utility and safety of LLMs in
clinical settings. Our objective was to determine whether two LLMs can serve
information needs submitted by physicians as questions to an informatics
consultation service in a safe and concordant manner. Sixty six questions from
an informatics consult service were submitted to GPT-3.5 and GPT-4 via simple
prompts. 12 physicians assessed the LLM responses' possibility of patient harm
and concordance with existing reports from an informatics consultation service.
Physician assessments were summarized based on majority vote. For no questions
did a majority of physicians deem either LLM response as harmful. For GPT-3.5,
responses to 8 questions were concordant with the informatics consult report,
20 discordant, and 9 were unable to be assessed. There were 29 responses with
no majority on "Agree", "Disagree", and "Unable to assess". For GPT-4,
responses to 13 questions were concordant, 15 discordant, and 3 were unable to
be assessed. There were 35 responses with no majority. Responses from both LLMs
were largely devoid of overt harm, but less than 20% of the responses agreed
with an answer from an informatics consultation service, responses contained
hallucinated references, and physicians were divided on what constitutes harm.
These results suggest that while general purpose LLMs are able to provide safe
and credible responses, they often do not meet the specific information need of
a given question. A definitive evaluation of the usefulness of LLMs in
healthcare settings will likely require additional research on prompt
engineering, calibration, and custom-tailoring of general purpose models.Comment: 27 pages including supplemental informatio
Recommended from our members
Impact of mental illness on end-of-life emergency department use in elderly patients with gastrointestinal malignancies.
BackgroundElderly patients with gastrointestinal cancer and mental illness have significant comorbidities that can impact the quality of their care. We investigated the relationship between mental illness and frequent emergency department (ED) use in the last month of life, an indicator for poor end-of-life care quality, among elderly patients with gastrointestinal cancers.MethodsWe used SEER-Medicare data to identify decedents with gastrointestinal cancers who were diagnosed between 2004 and 2013 and were at least 66 years old at time of diagnosis (median age: 80 years, range: 66-117 years). We evaluated the association between having a diagnosis of depression, bipolar disorders, psychotic disorders, anxiety, dementia, and/or substance use disorders and ED use in the last 30 days of life using logistic regression models.ResultsOf 160,367 patients included, 54,661 (34.1%) had a mental illness diagnosis between one year prior to cancer diagnosis and death. Patients with mental illness were more likely to have > 1 ED visit in the last 30 days of life (15.6% vs. 13.3%, p < 0.01). ED use was highest among patients with substance use (17.7%), bipolar (16.5%), and anxiety disorders (16.4%). Patients with mental illness who were male, younger, non-white, residing in lower income areas, and with higher comorbidity were more likely to have multiple end-of-life ED visits. Patients who received outpatient treatment from a mental health professional were less likely to have multiple end-of-life ED visits (adjusted odds ratio 0.82, 95% confidence interval 0.78-0.87).ConclusionsIn elderly patients with gastrointestinal cancers, mental illness is associated with having multiple end-of-life ED visits. Increasing access to mental health services may improve quality of end-of-life care in this vulnerable population
Impact of mental illness on end-of-life emergency department use in elderly patients with gastrointestinal malignancies.
BackgroundElderly patients with gastrointestinal cancer and mental illness have significant comorbidities that can impact the quality of their care. We investigated the relationship between mental illness and frequent emergency department (ED) use in the last month of life, an indicator for poor end-of-life care quality, among elderly patients with gastrointestinal cancers.MethodsWe used SEER-Medicare data to identify decedents with gastrointestinal cancers who were diagnosed between 2004 and 2013 and were at least 66 years old at time of diagnosis (median age: 80 years, range: 66-117 years). We evaluated the association between having a diagnosis of depression, bipolar disorders, psychotic disorders, anxiety, dementia, and/or substance use disorders and ED use in the last 30 days of life using logistic regression models.ResultsOf 160,367 patients included, 54,661 (34.1%) had a mental illness diagnosis between one year prior to cancer diagnosis and death. Patients with mental illness were more likely to have > 1 ED visit in the last 30 days of life (15.6% vs. 13.3%, p < 0.01). ED use was highest among patients with substance use (17.7%), bipolar (16.5%), and anxiety disorders (16.4%). Patients with mental illness who were male, younger, non-white, residing in lower income areas, and with higher comorbidity were more likely to have multiple end-of-life ED visits. Patients who received outpatient treatment from a mental health professional were less likely to have multiple end-of-life ED visits (adjusted odds ratio 0.82, 95% confidence interval 0.78-0.87).ConclusionsIn elderly patients with gastrointestinal cancers, mental illness is associated with having multiple end-of-life ED visits. Increasing access to mental health services may improve quality of end-of-life care in this vulnerable population
Recommended from our members
The clinical and financial cost of mental disorders among elderly patients with gastrointestinal malignancies.
The clinical and financial effects of mental disorders are largely unknown among gastrointestinal (GI) cancer patients. Using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database, we identified patients whose first cancer was a primary colorectal, pancreatic, gastric, hepatic/biliary, esophageal, or anal cancer as well as those with coexisting depression, anxiety, psychotic, or bipolar disorder. Survival, chemotherapy use, total healthcare expenditures, and patient out-of-pocket expenditures were estimated and compared based on the presence of a mental disorder. We identified 112,283 patients, 23,726 (21%) of whom had a coexisting mental disorder. Median survival for patients without a mental disorder was 52 months (95% CI 50-53 months) and for patients with a mental disorder was 43 months (95% CI 42-44 months) (p < 0.001). Subgroup analysis identified patients with colorectal, gastric, or anal cancer to have a significant association between survival and presence of a mental disorder. Chemotherapy use was lower among patients with a mental disorder within regional colorectal cancer (43% vs. 41%, p = 0.01) or distant colorectal cancer subgroups (71% vs. 63%, p < 0.0001). The mean total healthcare expenditures were higher for patients with a mental disorder in first year following the cancer diagnosis (increase of 15,777-1,926, 95% CI 2091). There are a substantial number of GI cancer patients who have a coexisting mental disorder, which is associated with inferior survival, higher healthcare expenditures, and greater personal financial burden
Biopolymer based nanofertilizers applications in abiotic stress (drought and salinity) control
With ever growing world population, environmental changes, uncontrolled urbanization, food security is emerging as an important issue with every passing day. Researchers from divergent fields including plant sciences are developing strategies and technologies to restrict the problem of food security. Plant stresses such as drought and salinity can be termed as key players in the alleviation of overall crop yield around the world. Both the stresses hit the nutrient uptake ability of the plant leaving it venerable to environmental conditions. Nano fertilizers are emerging at a new solution for handling the major plant problems like salinity and drought. The application of nanoparticles has advantages such as enhanced surface area and enhanced reactivity. The safe, targeted and slow delivery of plant nutrients can be carried-out by using bio-based nanoparticle carriers. A large variety of biopolymers have been tested for this purpose such as chitosan, cellulose, alginate and chitin. In the current book chapter, we provide an overview of the basic concepts of Nano fertilizers and its role in alleviation of salinity and drought stress. Also, the control release of these Nano fertilizers through different matrices have been discussed in detail with recent studies